Sarcoma News

The number of prescriptions written for physician-aided deaths in Oregon has increased annually since it became the first state to enact the Death with Dignity Act in 1997, according to a retrospective cohort study published in JAMA Oncology.

Sexual and gender minorities diagnosed with cancer may encounter specific challenges, including discrimination and greater risks for anxiety and depression, according to an ASCO guideline published in Journal of Clinical Oncology.

The burden of cancer in HIV–positive patients is projected to decrease by 2030, mostly driven by declines in non-Hodgkin lymphoma and Kaposi sarcoma, according to data presented at the American Association for Cancer Research Annual Meeting.

The FDA granted orphan drug designation to Yeliva for the treatment of cholangiocarcinoma, according to the drug’s manufacturer.

International and private sector collaboration, as well as the $1.8 billion in federal funding directed toward the NIH as part of the 21st Century Cures Act, are two major accomplishments of the national cancer moonshot initiative achieved in the past year, according to former Vice President Joe Biden.

Overall cancer death rates continued to decrease in men, women and children among all racial and ethnic groups, according to the Annual Report to the Nation on the Status of Cancer.

Adult survivors of adolescent and young adult cancers were more likely to experience preterm birth, low birth weight and cesarean delivery compared with births by women never diagnosed with cancer, according to study results.

Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to ASCO’s State of Cancer Care in America: 2017 report released today.

Many of the nation’s leading research organizations and cancer centers have voiced their opposition to President Donald J. Trump’s proposed budget, which includes a $5.8 billion cut to NIH funding in 2018.

Chemotherapy directed to limbs with advanced soft tissue sarcoma preserved arms and legs that otherwise might have required amputation, according to a 22-year research study published in Journal of the American College of Surgeons.